US Patent Issued to Regeneron Pharmaceuticals on Oct. 14 for "Bispecific anti-PSMA x anti-CD28 antibodies and uses thereof" (New York Inventors)

ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,441,800, issued on Oct. 14, was assigned to Regeneron Pharmaceuticals Inc. (Tarrytown, N.Y.).

"Bispecific anti-PSMA x anti-CD28 antibodies and uses thereof" was invented by Andrew J. Murphy (Croton-on-Hudson, N.Y.), Dimitris Skokos (New York), Janelle Waite (Bronx, N.Y.), Erica Ullman (Yorktown Heights, N.Y.), Aynur Hermann (New York), Eric Smith (New York), Lauric Haber (Rye Brook, N.Y.) and George D. Yancopoulos (Yorktown Heights, N.Y.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides bispecific antigen-binding molecules comprising a first antigen-binding domain that specifically binds human CD28, and a second antigen-bindi...